MUCORMYCOSIS
Clinical trials for MUCORMYCOSIS explained in plain language.
Never miss a new study
Get alerted when new MUCORMYCOSIS trials appear
Sign up with your email to follow new studies for MUCORMYCOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a gentler antifungal drug protect liver transplant patients from deadly mold without risking organ rejection?
Disease control Not yet recruitingInvasive mold infections are a major threat to liver transplant recipients, with mortality rates as high as 90%. The standard treatment, voriconazole, can interfere with anti-rejection drugs, increasing the risk of graft loss. This trial tests whether liposomal amphotericin B (Am…
Matched conditions: MUCORMYCOSIS
Phase: NA • Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Tailoring antifungal doses for seniors: a precision approach
Knowledge-focused Not yet recruitingThis study aims to find the best dose of isavuconazole, an antifungal drug, for patients over 60 with invasive fungal infections. Researchers will monitor drug levels in the blood and adjust doses to improve treatment and reduce side effects. The goal is to create personalized do…
Matched conditions: MUCORMYCOSIS
Sponsor: Chinese PLA General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC